Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VI

Ana C M Azevedo1, Osvaldo Artigalás, Leonardo Vedolin

  • 1Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.

Abstract

Insights

Mucopolysaccharidosis type VI (MPS VI) patients frequently show brain MRI abnormalities, including dilated perivascular spaces and white matter lesions. These brain changes in MPS VI do not correlate with IQ scores, despite some patients having below-normal IQ.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Mucopolysaccharidosis type VI (MPS VI) is a rare lysosomal storage disorder resulting from deficient N-acetylgalactosamine 4-sulfatase activity.
  • MPS VI is typically not associated with intellectual disability.

Purpose of the Study:

  • To investigate brain magnetic resonance imaging (MRI) findings in patients with MPS VI.
  • To correlate these MRI findings with clinical and biochemical data, including IQ scores.

Main Methods:

  • The study included 25 MPS VI patients evaluated through clinical assessment, IQ testing, urinary glycosaminoglycans (GAG) analysis, and brain MRI.
  • Statistical analyses were performed to identify correlations between various parameters.

Main Results:

  • The majority of patients (19/21) exhibited abnormal brain MRI findings, most commonly dilated perivascular spaces and white matter lesions.
  • Significant correlations were observed between age and white matter lesion load, and between normalized cerebral volume and deficits in height and weight.
  • No correlation was found between urinary GAG levels and brain MRI findings, nor between MRI findings and IQ scores.

Conclusions:

  • Brain MRI abnormalities are frequent in MPS VI patients.
  • Abnormal IQ scores can occur in MPS VI patients independently of observed brain MRI changes.
  • Further research is needed to validate these findings and understand the underlying mechanisms.